Shareholding disclosure

Santhera Pharmaceuticals Holding AG

Declared position

59.61%

Threshold

Crossed downwards

Timeline

Published

02.12.2020

Transaction

24.11.2020

Voting rights breakdown

Voting rights acquired9.91%
Voting rights sold59.61%
Below threshold0%

Notice details

CategorySingle shareholder
ExchangeXSWX

Notification ID

TAKBU00018

Beneficial owner

Santhera Pharmaceuticals Holding AG

Declared address

Santhera Pharmaceuticals Holding AG, Pratteln

acquisition and disposal of shares on November 24, 2020; also regarding certain sales positions

These figures aggregate public disclosures. They are not investment advice.

Source: SIX Exchange Regulation

insider24.ch

Never miss a market signal again

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open